The Role of Rotational Thromboelastometry in High-Risk-of-Bleeding Endoscopic Procedures in Patients with Decompensated Liver Cirrhosis
Authors:
- Irina GirleanuIrina Girleanu
- Laura HuibanLHLaura Huiban
- Cristina MuzicaCMCristina Muzica
- Camelia CojocariuCCCamelia Cojocariu
- Cătălin Victor SfartiCSCătălin Victor Sfarti
- Stefan ChiriacSCStefan Chiriac
- Sebastian ZenoviaSZSebastian Zenovia
- Gheorghe G. BalanGBGheorghe G. Balan
- Raluca AvramRARaluca Avram
- Ana Maria SîngeapAna Maria Sîngeap
- Iulian BuzincuIulian Buzincu
- Ana Maria TrofinATAna Maria Trofin
Open Access
- 25 April 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (9) , 1289
Abstract
Background/Objectives: This study aimed to evaluate the differences between two blood product transfusion protocols [a standard coagulation (SC) group and a rotational thromboelastometry (ROTEM) group] in patients with decompensated liver cirrhosis (LC) undergoing high-bleeding-risk endoscopic procedures. Methods: Between December 2024 and March 2025, we conducted a prospective cohort study including adult decompensated cirrhotic patients who needed prophylactic blood product transfusion before high-bleeding-risk endoscopic procedures. The prophylactic blood product transfusion strategy in the SC group was based on conventional coagulation tests (INR, platelets, and fibrinogen), and in the ROTEM group on viscoelastic parameters. Results: A total of 72 patients were included in this study (36 patients in each group); most were male (63.9%), Child–Pugh B (54.2%), and had LC with a predominance of alcoholic etiology (51.4%). There were no clinically significant differences regarding the baseline characteristics between the study groups. The most frequent endoscopic procedure was polypectomy (76.4%). Postinterventional bleeding occurred after eight procedures in the SC group and after four procedures in the ROTEM group (p = 0.206). Endoscopic hemostasis was effective. Patients from the ROTEM group received fewer FFP transfusions than the SC group (5.6% vs. 69.4%; p < 0.0001). Blood product transfusion was needed less in patients evaluated using ROTEM compared with the SC group (41.2% vs. 100%; p < 0.0001). There were no differences in the length of hospital stay (p = 0.618) or 30-day mortality (p = 0.643) between the two study groups. Conclusions: ROTEM-guided transfusion management was associated with a significant reduction in blood product use compared with standard coagulation test-based management. However, this difference should be interpreted in the context of the distinct transfusion thresholds applied in the two groups, as the standard coagulation arm followed predefined laboratory-based criteria that may have increased the likelihood of prophylactic transfusion. No statistically significant differences were observed in bleeding complications, length of hospital stay, or 30-day mortality. Therefore, these findings reflect differences in transfusion strategies rather than demonstrating clinical superiority of ROTEM-based management and should be considered preliminary.Keywords
Funding Information
- Universitatea de Medicina și Farmacie Grigore T. Popa - Iasi (13536/2024)
This publication has 46 references indexed in Scilit:
- Comparison of relaxed verses standard cut-offs of rotational thromboelastometry for guiding blood product use before invasive procedures in advanced cirrhosis: a randomized controlled trialHepatology International, 2025
- Rotational Thromboelastometry Reduces the Need for Preemptive Transfusion in Cirrhosis: A Randomized Controlled Trial (NCT:05698134)Journal of Clinical and Experimental Hepatology, 2024
- Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2020
- Determining the true incidence of acute transfusion reactions: Active surveillance at a specialized liver centerHematology, Transfusion and Cell Therapy, 2020
- A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related ProceduresDigestive Diseases and Sciences, 2019
- Bleeding after invasive procedures is rare and unpredicted by platelet counts in cirrhotic patients with thrombocytopeniaEuropean Journal of Internal Medicine, 2017
- Procoagulant imbalance in patients with non-alcoholic fatty liver diseaseJournal of Hepatology, 2017
- Thrombelastography‐guided blood product use before invasive procedures in cirrhosis with severe coagulopathy: A randomized, controlled trialHepatology, 2015
- Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver DiseaseClinical Gastroenterology and Hepatology, 2010
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosisJournal of Hepatology, 2010